Bioequivalence of Ertugliflozin/Metformin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components-Reference-Cited by-同舟云学术

Bioequivalence of Ertugliflozin/Metformin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components

Published:2019-06-17 Issue:1 Volume:9 Page:50-61
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Dawra Vikas Kumar¹,Liang Yali¹,Wei Hua²,Pelletier Kathleen¹,Shi Haihong¹,Hickman Anne¹,Bass Almasa³,Terra Steven G.⁴,Zhou Susan⁵,Krishna Rajesh⁵,Sahasrabudhe Vaishali¹

Affiliation:

1. Pfizer Inc. Groton CT USA

2. Pfizer Shanghai China

3. Pfizer Inc. Durham NC USA

4. Pfizer Inc. Andover MA USA

5. Merck & Co., Inc. Kenilworth NJ USA

Funder

Merck Sharp and Dohme

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.703

Reference26 articles.

1. Centers for Disease Control and Prevention.National diabetes statistics report 2017.https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Published 2017. Accessed January 22 2019.

2. International Diabetes Federation. IDF Diabetes Atlas 8th edn.Brussels Belgium: International Diabetes Federation.http://diabetesatlas.org/resources/2017-atlas.html. Published 2017. Accessed January 22 2019.

3. Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus

4. Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

5. Effect of food on the pharmacokinetics of ertugliflozin and its fixed‐dose combinations ertugliflozin/sitagliptin and ertugliflozin/metformin;Sahasrabudhe V;Clin Pharmacol Drug Dev

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Profile and Comparative Bioavailability of an Oral Fixed‐Dose Combination of Metformin and Acetylsalicylic Acid (Aspirin);Clinical Pharmacology in Drug Development;2024-07-22

2. Effect and safety of combined Gegen Qinlian decoction/metformin in the treatment of diabetes mellitus in patients, and its influence on serum C peptide and glycosylated hemoglobin;Tropical Journal of Pharmaceutical Research;2022-06-18

3. Ertugliflozin + metformin as a treatment option for type 2 diabetes;Expert Opinion on Pharmacotherapy;2021-07-15

4. Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States;Clinical Pharmacology in Drug Development;2020-11-02

5. Ertugliflozin in type 2 diabetes: a profile of its use;Drugs & Therapy Perspectives;2019-07-03